… We in fact explored such learning styles in our study which focused on knowledge and
awareness of biosimilars among patients attending oncology practices in Colorado[10]. Similar to …

… teams in Colorado, USA toward SDM and biosimilars. We assessed … among gastroenterology
teams in sharing knowledge about SDM and biosimilars with their colleagues and patients, …

… co-developed by Kantar with Ellis Consulting, an independent recruiter that has grown and
maintained the panel for over 20 years. This co… the same level of knowledge, awareness, and …

… oncology biosimilars and identifies current knowledge gaps in … A US study of patients with
various types of cancers and … participants had limited awareness of biosimilars. Furthermore, …

… utilization and their 74 relationships to utilization rates in The US Oncology Network (USON) …
awareness. 205 Research on biosimilar uptake focuses heavily on the lack of knowledge …

… their knowledge of biosimilars. RESULTS: This study included 185 … of knowledge,
understanding, and comfort of prescribing … Dr Alexander is currently employed at Merck & Co., Inc., …

… gaps [8-10] and apprehension about biosimilar safety and efficacy particularly … knowledge
and attitudes towards biosimilars among oncologists to grow our understanding of biosimilar …

… was Humulin developed by Eli lilly & Co. in the 70s and was … basic understanding of the
definition of biological and biosimilar … ’ designation to any Biosimilars agent in Oncology (22), …

… knowledge and understanding of biosimilars. Although a survey by the National Comprehensive
Cancer … method to gauge biosimilar implementation and understanding in US real-…

… for a lack of knowledge among health care workers about biosimilars and how they differ from
… of 20 US and European studies on the use and understanding of biosimilars among health …